There is currently no treatment or cure for ALS, also known as Lou Gehrig's disease. Several hospitals across the U.S. are testing a new stem cell therapy that doctors and patients hope will help. Dr. Mallika Marshall reports from Boston.
Stem Cell Transplant Studies Raise Hopes Of Treatment For ALSStem Cell Transplant Studies Raise Hopes Of Treatment For ALS - Medical News Today
Such ALS stem cell treatment is not the same thing as stem cell transplants, which are procedures used to manage certain cancers and autoimmune diseases. Stem cell transplants work by replacing the blood stem cells that live in the bone marrow. ...
NurOwn is an investigational mesenchymal stem cell (MSC)-based therapy, being developed by BrainStorm Cell Therapeutics, for the treatment of ALS. It uses MSCs taken from the patient that are then modified to develop into cells that promote nerve cell growth and survival. NSI-566 NSI-566 is...
"We took one very substantial step forward to finding in the foreseeable future a treatment that may delay progression of the disease, and may even induce some improvement." For the study, published online January 11 in JAMA Neurology, the researchers used autologous mesenchymal stem cells from ...
In the first trial of its kind, the Cedars-Sinai team showed that delivery of this combined treatment is safe in humans. The findings were reported today in the peer-reviewed journal Nature Medicine. "Using stem cells is a powerful way to deliver important proteins to the brain or spinal co...
Private equity in autism care, a watershed FDA approval, and the future of ALS treatment BiotechAdam Feuerstein STAT Plus:Brainstorm to seek FDA approval for ALS stem-cell treatment, despite agency objections PharmalotEd Silverman STAT Plus:FDA’s decision to review a Biogen ALS drug is met wit...
BookmarkedStem cell treatment goes from lab to operating roombyMiriam Falco, CNN Medical News Managing Editor(cnn.com) Imagine having your back cut open, part of your spine removed, a stabilizing device that resembles a mini oil rig mounted on your back, the outer membrane of your spinal cor...
For up to 60 months after surgery, none of the patients manifested severe adverse effects or increased disease progression because of the treatment, it said. Eleven of the patients died, and two underwent tracheotomy "as a result of the natural history of the disease". "Our results show that...
Treatment name: CNS10-NPC-GDNF Administration: Surgically administered into the spinal cord or brain Clinical testing: Phase 1/2a trial completed; currently in a Phase 1 trialHow does CNS10-NPC-GDNF work?ALS is caused by the death of motor neurons, which are nerve cells that control the ...